Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;89(5):621-627.
doi: 10.1111/cen.13841. Epub 2018 Sep 20.

Comprehensive Screening Shows That Mutations in the Known Syndromic Genes Are Rare in Infants Presenting With Hyperinsulinaemic Hypoglycaemia

Affiliations
Free PMC article

Comprehensive Screening Shows That Mutations in the Known Syndromic Genes Are Rare in Infants Presenting With Hyperinsulinaemic Hypoglycaemia

Thomas W Laver et al. Clin Endocrinol (Oxf). .
Free PMC article

Abstract

Objective: Hyperinsulinaemic hypoglycaemia (HH) can occur in isolation or more rarely feature as part of a syndrome. Screening for mutations in the "syndromic" HH genes is guided by phenotype with genetic testing used to confirm the clinical diagnosis. As HH can be the presenting feature of a syndrome, it is possible that mutations will be missed as these genes are not routinely screened in all newly diagnosed individuals. We investigated the frequency of pathogenic variants in syndromic genes in infants with HH who had not been clinically diagnosed with a syndromic disorder at referral for genetic testing.

Design: We used genome sequencing data to assess the prevalence of mutations in syndromic HH genes in an international cohort of patients with HH of unknown genetic cause.

Patients: We undertook genome sequencing in 82 infants with HH without a clinical diagnosis of a known syndrome at referral for genetic testing.

Measurements: Within this cohort, we searched for the genetic aetiologies causing 20 different syndromes where HH had been reported as a feature.

Results: We identified a pathogenic KMT2D variant in a patient with HH diagnosed at birth, confirming a genetic diagnosis of Kabuki syndrome. Clinical data received following the identification of the mutation highlighted additional features consistent with the genetic diagnosis. Pathogenic variants were not identified in the remainder of the cohort.

Conclusions: Pathogenic variants in the syndromic HH genes are rare; thus, routine testing of these genes by molecular genetics laboratories is unlikely to be justified in patients without syndromic phenotypes.

Keywords: genetic screening; hyperinsulinaemia hypoglycaemia of infancy; medical genetics; molecular diagnostics; mutation; neonatal hyperinsulinism; syndrome.

Figures

Figure 1
Figure 1
KMT2D variant hg19/GRCh37:g.49420017_49420018del/NM_003482:c.15731_15732del/p.Lys5244Serfs*13. Visualized in integrative genomics viewer (IGV). It shows the sequencing reads. (horizontal grey bars) mapping to exon 48 of the KMT2D gene located at genomic position 49,420,017 on chromosome 12. The reference nucleotide sequence and the amino acid translation are provided under the sequencing reads. The heterozygous deletion of TT is illustrated by ‐2‐ and is present in 15 of the 25 sequencing reads present at this position. The deletion causes a frameshift.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Maiorana A, Dionisi‐Vici C. Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties. J Inherit Metab Dis. 2017;40:531‐542. - PubMed
    1. Barthlen W, Mohnike W, Mohnike K. Techniques in pediatric surgery: congenital hyperinsulinism. Horm Res Paediatr. 2010;74:438‐443. - PubMed
    1. Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol. 2013;168:557‐564. - PMC - PubMed
    1. Munns C, Batch J. Hyperinsulinism and Beckwith‐Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed. 2001;84:F67‐F69. - PMC - PubMed
    1. Baujat G, Rio M, Rossignol S, et al. Paradoxical NSD1 mutations in Beckwith‐Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am J Hum Genet. 2004;74:715‐720. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts

Feedback